Insights

Targeting Biopharma CYTENA’s automated single-cell isolation and clonality verification capabilities align with large biopharma and CDMO needs for rapid monoclonal antibody development, enabling faster timelines and reduced cross-contamination risk.

Automated Workflows The C.STATION platform and related automated cell line development workflows offer a compelling upsell to customers seeking end-to-end automation, potentially expanding footprint with existing lab infrastructure.

High Viability Advantage Emphasize the gentle handling and high cell viability without labeling as a differentiator for biologics production and cell line development, reducing costly failures during cloning and expansion.

Validation and Compliance Image-backed clonality assurance and contamination-free disposable cartridges provide strong documentation and quality control features that can support regulatory submissions and audit readiness for top-tier pharma clients.

Strategic Partnerships Past collaborations with ExcellGene and rapid news about C.WASH PLUS signal opportunities to partner with contract development and manufacturing organizations to co-develop automated workflows for biotherapeutics.

CYTENA Tech Stack

CYTENA uses 8 technology products and services including Contao, GitHub Actions, Goober, and more. Explore CYTENA's tech stack below.

  • Contao
    Content Management System
  • GitHub Actions
    Devops
  • Goober
    Javascript Libraries
  • Render
    Platform As A Service
  • X-Content-Type-Options
    Web & Portal Technology
  • HTTP/3
    Web & Portal Technology
  • gRPC
    Web Frameworks
  • Google Tag Manager for WordPress
    Web Platform Extensions

Media & News

CYTENA's Email Address Formats

CYTENA uses at least 1 format(s):
CYTENA Email FormatsExamplePercentage
First.Last@cytena.comJohn.Doe@cytena.com
96%
Last@cytena.comDoe@cytena.com
3%
First.Middle.Last@cytena.comJohn.Michael.Doe@cytena.com
1%

Frequently Asked Questions

Where is CYTENA's headquarters located?

Minus sign iconPlus sign icon
CYTENA's main headquarters is located at 5 Zollhallenstraße Freiburg im Breisgau, Baden-württemberg 79106 Germany. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is CYTENA's official website and social media links?

Minus sign iconPlus sign icon
CYTENA's official website is cytena.com and has social profiles on LinkedInCrunchbase.

What is CYTENA's SIC code NAICS code?

Minus sign iconPlus sign icon
CYTENA's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does CYTENA have currently?

Minus sign iconPlus sign icon
As of May 2026, CYTENA has approximately 58 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Head Of Sales Europe - Biopharma: J. S.Head Of Hardware Development & Product Owner: L. L.Head Of Global Supply Chain: M. G.. Explore CYTENA's employee directory with LeadIQ.

What industry does CYTENA belong to?

Minus sign iconPlus sign icon
CYTENA operates in the Biotechnology Research industry.

What technology does CYTENA use?

Minus sign iconPlus sign icon
CYTENA's tech stack includes ContaoGitHub ActionsGooberRenderX-Content-Type-OptionsHTTP/3gRPCGoogle Tag Manager for WordPress.

What is CYTENA's email format?

Minus sign iconPlus sign icon
CYTENA's email format typically follows the pattern of First.Last@cytena.com. Find more CYTENA email formats with LeadIQ.

How much funding has CYTENA raised to date?

Minus sign iconPlus sign icon
As of May 2026, CYTENA has raised $3.4M in funding. The last funding round occurred on Mar 26, 2019 for $3.4M.

When was CYTENA founded?

Minus sign iconPlus sign icon
CYTENA was founded in 2014.
CYTENA logo

CYTENA

Biotechnology ResearchBaden-württemberg, Germany51-200 Employees

CYTENA is a biotechnology instruments company that specializes in automated single-cell handling to accelerate biotherapeutic drug development. Its systems isolate individual cells with imaging-based confirmation of clonality and can work with a variety of cell types, including bacteria, while maintaining high viability without cell labeling. A disposable cartridge design helps ensure sample purity and minimizes cross-contamination, facilitating integration into existing workflows. The company has developed the C.STATION platform, a fully automated cell line development system that supports cloning, selection of high-producing clones, and upscaling.

Based in Freiburg im Breisgau, Baden-Württemberg, CYTENA operates within the biotechnology research sector, serving pharmaceutical companies and academic researchers pursuing efficient cell line development and single-cell analysis. Its instruments are used by numerous large pharmaceutical firms to rapidly generate monoclonal cell lines for antibody development with minimized cross-contamination risk, and they support academic research in cancer, autoimmune disease, and genomics, with a May 2024 launch of C.WASH PLUS illustrating ongoing product development.

Section iconCompany Overview

Headquarters
5 Zollhallenstraße Freiburg im Breisgau, Baden-württemberg 79106 Germany
Website
cytena.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
51-200

Section iconFunding & Financials

  • $3.4M

    CYTENA has raised a total of $3.4M of funding over 3 rounds. Their latest funding round was raised on Mar 26, 2019 in the amount of $3.4M.

  • $10M$25M

    CYTENA's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $3.4M

    CYTENA has raised a total of $3.4M of funding over 3 rounds. Their latest funding round was raised on Mar 26, 2019 in the amount of $3.4M.

  • $10M$25M

    CYTENA's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.